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Abstract The milk-producing alveolar epithelial cells secrete
milk that remains after birth the principal source of nutrients for
neonates. Milk secretion and composition are highly regulated
processes via integrated actions of hormones and local factors
which involve specific receptors and downstream signal trans-
duction pathways. Overall milk composition is similar among
mammalian species, although the content of individual con-
stituents such as lipids may significantly differ from one
species to another. The milk lipid fraction is essentially com-
posed of triglycerides, which represent more than 95 % of the
total lipids in human and commercialized bovine milk.
Though sterols, including cholesterol, which is the major milk
sterol, represent less than 0.5 % of the total milk lipid fraction,
they are of key importance for several biological processes.
Cholesterol is required for the formation of biological mem-
branes especially in rapidly growing organisms, and for the
synthesis of sterol-based compounds. Cholesterol found in
milk originates predominantly from blood uptake and, to a
certain extent, from local synthesis in the mammary tissue.
The present review summarizes current knowledge on cellular
mechanisms and regulatory processes determining intra- and
transcellular cholesterol transport in the mammary gland.
Cholesterol exchanges between the blood, the mammary al-
veolar cells and the milk, and the likely role of active choles-
terol transporters in these processes are discussed. In this
context, the hormonal regulation and signal transduction path-
ways promoting active cholesterol transport as well as poten-
tial regulatory crosstalks are highlighted.
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Abbreviations
ABC transporter ATP-binding cassette transporter
ACAT Acyl-coenzyme A: cholesterol
acyltransferase
ApoA-I Apolipoprotein A-I
CEH Cholesteryl ester hydrolase
CLD Cytoplasmic lipid droplets




LAL Lysosomal acid lipase
LDL Low density lipoprotein
LPL Lipoprotein lipase
LXR Liver X receptor
MAPK Mitogen-activated protein kinase
MEC Alveolar mammary epithelial cell
MFG Milk fat globule
NPC Niemann-Pick type C
OSBP Oxysterol-binding protein
ORP OSBP-releated protein
PPAR Peroxisome proliferator-activated receptor
PREB Prolactin regulatory element binding
SR-BI Scavenger receptor class B type I
SREBP Sterol response element binding protein
VLDL Very low density lipoprotein
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such as the formation of biological membranes and the syn-
thesis of sterol-based compounds. Experiments performed in
ruminants by using radioactive compound showed that ap-
proximately 20 % of cholesterol in milk originates from de
novo synthesis in the mammary tissues while the major frac-
tion of cholesterol (~80 %) is derived from the blood serum
[1]. Cholesterol is released into milk by milk-producing alve-
olar mammary epithelial cells (MEC), which are in close
proximity and interaction with other mammary cell types such
as myoepithelial cells. Altogether, these cells constitute the
epithelial barrier separating the blood from alveolar compart-
ments. As depicted in Fig. 1, MEC are glandular polarized
cells with functionally distinct basolateral and apical plas-
ma membrane domains. It is established that milk con-
stituents enter the milk compartment by various mecha-
nisms, which belong to the paracellular and transcellular
routes of transport [2, 3]. The transport of cholesterol
across the epithelial barrier may also involve active trans-
port by membrane transporters such as ATP-binding cassette
(ABC) transporters [4]. The present review summarizes the
mechanisms mediating the transcellular transport of choles-
terol into the milk and describes the regulatory mechanisms
involved.
Health and Disease Aspects of Cholesterol
Cholesterol is a neutral lipid, which is a structural constituent
of biological membranes. It is accumulated in liquid-ordered,
detergent-resistant membrane domains called lipid rafts,
which are an important platform for signal transduction path-
ways mediating various cellular processes including cell
growth, survival, and others [5, 6]. Moreover, cholesterol is
a precursor molecule in the synthesis of multiple sterol-based
compounds (e.g. steroid hormones, vitamin D). Cholesterol
demand is elevated during the period of a rapid organ growth,
development and maturation, such as during fetal and early
postnatal life when a rapid growth of tissues and key systems
Fig. 1 Overview of potential cholesterol transport mechanisms in mam-
mary alveolar epithelial cells (MEC). Similar to uptake mechanisms
shown in other polarized cell types [141], MEC are supposed to take up
cholesterol both as free cholesterol (FC) and cholesteryl esters (CE) from
circulating chylomicrons (CM), very low density lipoprotein (VLDL),
low-density lipoproteins (LDL) and high-density lipoprotein (HDL) via
various mechanisms involving 1) LDL-related protein (LRP), 2) receptor
mediated endocytosis of the LDL-receptor (LDL-R), and 3) receptor-
mediated uptake by the scavenger receptor class B type I (SR-B1). Addi-
tional cholesterol uptake is likely to occur by diffusional processes (4)
which may involve the action of cytosolic transport proteins such as the
steroidogenic acute regulatory protein (StAR). Cholesterol taken up from
the blood circulation in addition to cholesterol synthesized de novo in the
endoplasmic reticulum (ER) via the 3-hydroxy-3-methylglutaryl-CoA
(HMG-CoA)-reductase pathway (5) determine its intracellular pool. De-
pending on the cellular activities, FC can be esterified by acyl-coenzyme
A: cholesterol acyltransferase (ACAT) expressed in the ER and stored as
CE in lipid droplets (CLD) originating from the ER (6). It should be noted
that CE taken up from lipoprotein particles (e.g. via LDL-R) is initially
directed to endosomes where it is hydrolyzed by lysosomal acidic lipase
(LAL) and exported by Niemann-Pick type C (NPC) protein as FC (a),
whereas the CE taken up via SR-B1 are hydrolyzed to FC under the
action of cytosolic CE neutral hydrolase (b). ATP-binding cassette (ABC)
transporters such as ABCA1 and ABCG1 which are situated at the apical
and basolateral plasma membrane mediate the transfer of cholesterol to
extracellular acceptor proteins (e.g. lipid-poor apolipoprotein (apo)-A1;
pathway A). Pathway A requires the hydrolysis of ATP which, in the case
of ABCA1 induces conformational changes that allow apoA-1 binding
and further cholesterol transfer and release. As the localization and
transport activities of ABCG5 and ABCG8 in MEC have not been
investigated so far, these transporters are not illustrated. Pathway B shows
that cholesterol might cross the apical plasma membrane facing the
alveolar lumen by diffusion and binding to extracellular acceptors such
as BSA. The milk fat globule (MFG) secretion mode (pathway C)
involves the migration of cytoplasmic lipid droplets (CLD) from the ER
towards the apical membrane. At the apical plasma membrane domain,
CLD are progressively surrounded by the plasma membrane and then
pinched off into the milk. TJ tight junctions
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occurs [7]. Cholesterol ingested with milk or other dairy prod-
ucts is an important source of dietary cholesterol, which
influences cholesterolemia in humans. In this context, it has
been shown that the level of total circulating cholesterol in
6 months-aged babies fed with breast milk is similar to that in
adults [8]. Moreover, cholesterolemia was elevated in babies
fed with cholesterol-rich breast milk as compared to cholesterol-
lowmilk replacer [9]. Growing neonates were estimated to have
exceedingly high cholesterol intake by milk consumption [10]
which, however, seems to be not associated with elevated
risks of developing cardiovascular disease or other diseases
such as cancer later in life. In contrast, some studies have even
suggested that elevated cholesterolemia following
breastfeeding has beneficial health effects [11–13]. In this
regard, it is thought that LDL cholesterol contributes to settle
an efficient immune protection that lowers the mortality and
morbidity in neonates [14, 15]. This is explained by the fact
that high levels of circulating LDL particles might play a role
in facilitating the generation of antibodies. In analogy, it has
been observed that the susceptibility to infections and allergic
diseases was remarkably high in neonates having low LDL-
cholesterol as compared to those with elevated
cholesterolemia [15, 16], implying a reduced ability of gener-
ating antibodies in newborns exhibiting lower blood LDL-
cholesterol levels. Although a consensus about the beneficial
effects of cholesterol in childhood is still missing, there are
also studies proposing that elevated cholesterol blood levels in
neonates might have long-term health benefits, as it seems
lowering the vulnerability to develop cardiovascular diseases
in older age [11, 13]. The high cholesterol content of colos-
trum (Table 1) may be important to meet the elevated demand
in neonates. However, it can be assumed that, with develop-
mental growth and increased endogenous cholesterol
production by neonatal tissues [17], cholesterol provided
through the intake of mature milk is sufficient to fulfill the
tissue cholesterol demand. Cholesterol remains the major
sterol in milk, where it is found in both unesterified and
esterified forms. The latter represents approximately 10 % of
milk cholesterol [18]. However, the milk lipid content includ-
ing cholesterol varies considerably between species (Table 2).
Unlike young organisms, chronically elevated
cholesterolemia in adults is commonly associated with a vari-
ety of pathological conditions including cardiovascular dis-
ease [19]. It is therefore considered as a major characteristic of
disturbed cellular cholesterol homeostasis. There are several
reports indicating an association between high dietary choles-
terol intake and increased incidence of breast cancers espe-
cially in developed countries where diets are lipid-enriched
[20–22]. Elevated cholesterol levels were associated with
inflammatory breast cancer, which is a particularly invasive
and thereby lethal subset of breast cancer [23–25]. It has been
demonstrated that mammary tissues from inflammatory and
non-inflammatory breast cancer initially contain greater
amounts of cholesterol stored as lipid droplets in comparison
to healthy mammary cells [26]. More specifically, it was
shown that non-inflammatory breast cancer cells are reliant
on extracellular cholesterol supply to maintain intracellular
stores, while the inflammatory breast cancer cells are capable
of maintaining intracellular cholesterol concentration relative-
ly independent of extracellular cholesterol levels. In the con-
text of this study [26] the authors concluded that in the
absence of cholesterol in their immediate cellular microenvi-
ronment tumor cells might drive tumor cell invasion. Surely,
the importance of cholesterol regulation in cancer invasive-
ness requires further investigations. It is also important to note
that findings regarding the relationship between the lipid
profile and breast cancer are somehow conflicting. Since long,
there are data supporting an association between breast cancer
rates and fat intake [27–30]. Some case–control studies com-
paring the association between serum lipids and breast cancer
reported breast cancer patients with high plasma triglycerides
[31, 32] and, inversely, low cholesterol levels [31] as com-
pared to controls. Those findings disagreed, at least partly,
with reports that higher plasma triglycerides, cholesterol and
phospholipids are found in patients with breast cancer [33].
Table 1 Constituents in human milk
Milk constituent Colostrum Mature milk
Lactose (g/L) 20–30 67
Oligosaccharides (g/L) 22–24 12–14
Total protein (g/L) 16 9
Total lipids (%) 2 3.5
Triglycerides (% total lipids) 97–98 97–98
Cholesterol (% total lipids) 0.7–1.3 0.4–0.5
Cholesterol (mg/dL) >30 10–20
Cholesteryl esters (mg/dL)a ~5 ~1
Phospholipids (% total lipids) 1.1 0.6–0.8
Fatty acids (weight %) 88 88
This table has been adapted from [109, 143] with permission from
Elsevier. In the original references additional information for other milk
constituents (e.g. vitamins and minerals) can be found
a Specifications of cholesterol ester contents are taken from reference
[144]. Data are expressed as range or single values
Table 2 Total lipid and cholesterol levels in milk commonly consumed
by humans




Data are adapted from [18, 145, 146] and are published with permission
from Elsevier. Data shown are expressed as range or single values
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Cholesterol Transport Into Milk
Literature search on cholesterol transport in the mammary
gland demonstrates that this research area is relatively scarcely
investigated. Results from few previous studies significantly
improved our basic understanding of how various substrates,
including lipids, are transported across the epithelial barrier
into the milk compartment [1–3, 34, 35]. Recent studies
tempted to decipher the mechanisms of transcellular choles-
terol exchanges between the blood circulation,MEC, andmilk
compartments, has led to the speculation about possible mech-
anisms [4]. In general, the transport mechanisms determining
the transcellular passage of cholesterol into milk involve i) the
uptake of circulating cholesterol from the body reservoir (i.e.
blood circulation), where it circulates bound to carrier proteins
such as very low-density lipoproteins (VLDL), low-density
lipoproteins (LDL), high-density lipoproteins (HDL), and
chylomicrons [18], ii) passage across the basolateral plasma
membrane domains oriented towards the blood circulation, iii)
intracellular trafficking and compartmentalization, and ulti-
mately iiii) passage across the apical membrane facing the
alveolar lumen where milk resides (Fig. 1).
Mechanisms of Cholesterol Uptake at the Basolateral Plasma
Membrane
Figure 1 illustrates that cholesterol uptake in the mammary
gland involves co-existing enzyme and/or carrier-mediated as
well as receptor-mediated processes. In this context, it is not
yet clear which mechanism is the predominant gateway for
cholesterol uptake by MEC prior to its release into milk.
As depicted in Fig. 1, MEC are glandular cells containing
functionally distinct basolateral and apical plasma membrane
domains. The basolateral plasma membrane is the site of the
uptake of blood-borne milk constituents such as cholesterol.
As mentioned above, cholesterol in blood circulates bound to
intestinal chylomicrons or hepatic VLDL, LDL and HDL.
Mammary tissues, especially in the lactating state, exhibit
enzymatic activities that promote the uptake of circulating
cholesterol. It has been shown in rat mammary gland tissues
that lipoprotein lipase (LPL) is a key enzyme involved in
chylomicron and VLDL triglyceride hydrolysis and the sub-
sequent uptake of free cholesterol and cholesteryl esters
[36–39]. Moreover, LPL activity has been found in secretory
MEC (not depicted) and in milk [39]. LPL is synthesized in
parenchymal tissues including mammary epithelium, but the
enzyme is then translocated into the blood vessels where its
functional form is found at the surface of vascular endotheli-
um (for review see [40]). The LDL receptor-related protein
(LRP) represents an endocytic receptor that is expressed in
several tissues. LRP is a member of the LDL receptor family
that plays roles in various biological processes such as lipo-
protein metabolism. It has been reported that LRP, which
shows high similarity with the α2-microglobulin receptor,
recognizes several ligands including VLDL or LDL
transporting cholesterol [41]. The uptake of cholesterol is also
a receptor-mediated process that involves the LDL receptor
and scavenger receptor class B type I (SR-BI), respectively. A
study inmice showed that LDL binds to the LDL receptor, and
the complex is internalized by receptor-mediated endocytosis
via clathrin-coated vesicles. LDL particles dissociate from the
receptors, which are recycled back to the cell surface. The
degradation of the protein constituent of the LDL allows the
uptake of contained cholesteryl esters and free cholesterol
from circulating LDL remnants [42] (Fig. 1). The presence
of SR-BI in mammary gland tissues has been demonstrated,
and it is supposed to play a role in mediating the uptake of
cholesterol fromHDL [43]. In addition to the abovementioned
mechanisms, cholesterol uptake is likely to occur also by
diffusion across the basolateral membrane. Hence, when pri-
mary MEC were loaded in vitro with 3H-cholesterol without
specific cyclodextrin carriers such as methyl-β-cyclodextrin
or lipoproteins, an uptake of isotope cholesterol was found
[44]. An additional transport mechanism which implies a
facilitated passage of cholesterol across the plasma membrane
by cytosolic transporters such as steroidogenic acute regula-
tory protein (StAR) exhibiting high binding affinity for cho-
lesterol is also possible [45].
Mechanisms of Intracellular Cholesterol Transport
Cholesterol is taken up either as esterified or non-esterified
molecule, and is compartmentalized in cytosolic organelles
through the action of enzymes and intracellular transporters.
In all cells (polarized or non-polarized) cholesterol trafficking
is critical for the proper distribution of intracellular cholester-
ol. The fundamental transport pathways involved in intracel-
lular trafficking of cholesterol are described in detail below.
Cholesterol Transport Across Membranes of the Endoplasmic
Reticulum
An important cellular process mediating the intracellular
transport of cholesterol is the biosynthetic secretory pathway.
The endoplasmic reticulum (ER) is the site of cholesterol
synthesis, and different physiological mechanisms exist to
keep the steady-state content of cholesterol in the ER mem-
brane low. Acyl-coenzyme A: cholesterol acyltransferase
(ACAT) is an ER-associated enzyme, which exists in two
isoforms, type 1 and 2. In mammalian cells, ACAT catalyzes
the esterification of free cholesterol to cholesteryl esters and its
storage as cytoplasmic lipid droplets (CLD) when its level is
above the threshold [46]. It has been shown that mammary
tissues contain ACATactivity [47, 48]. This supports a role of
ACAT in the esterification process of free cholesterol obtained
from circulating carriers and its storage as cholesteryl esters,
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which are then released into milk by secretion. Studies in rats
showed variable ACAT activity between lactation and preg-
nancy, and a correlation between ACAT activity and
cholesteryl ester content was found [47, 49]. It was also
demonstrated that ACAT activity of microsomal preparations
from mammary gland tissues increased by more than 80 %
after supplementation with unesterified cholesterol [47, 49].
Recent studies in our laboratories using primary bovine MEC
revealed that inhibition of ACAT using a commercial antago-
nist (CI-976) resulted in an elevated cholesterol efflux poten-
tially due to the subsequent increase in the pool of unesterified
cholesterol available for efflux (unpublished data). Sustained
loading of MEC with free cholesterol seems to increase the
cellular accumulation of cholesteryl esters [44].
Cholesterol Transport Across Endosomal Membranes
and Intracellular Trafficking
Intracellular cholesterol trafficking relies on the actions of
enzymes as well as intracellular transporters expressed in the
mammary tissue, and represents an important step towards the
release of cholesterol into milk. Studies in rats and ruminants
showed that distinct cholesterol esters hydrolases, i.e. lyso-
somal acid lipase (LAL), cholesteryl ester hydrolase (CEH),
and hormone-sensitive lipase (HSL), are expressed in mam-
mary tissues including the lactating state when milk secretion
occurs [50–53]. As illustrated in the model of Fig. 1,
cholesteryl esters taken up from circulating LDL are supposed
to be directed to the endosomes from where they are
transported towards cellular compartments including the api-
cal plasma membrane which is in contact with the alveolar
milk [54]. The trafficking of cholesteryl esters taken up from
circulating LDL involves i) the cleavage of the cholesteryl
esters by LAL in the lysosomes ii) the binding of the free
cholesterol by the lysosomal membrane transporter Niemann-
Pick type C (NPC) type 2, iii) the transfer to NPC1, and iiii)
the final export to other cellular compartments for storage or
release into milk (Fig. 1). Cholesteryl esters that are stored in
CLD after esterification by ACAT, or that entered the MEC by
SR-B1-mediated uptake at the basolateral membrane, are
hydrolyzed to produce free cholesterol susceptible to be trans-
ferred into the milk. The key role of NPC in mediating the
inter-membrane cholesterol trafficking [55] became evident
when mutations of the NPC gene were associated with
Niemann–Pick type C disease, a disorder characterized by
the accumulation of cholesterol and glycosphingolipids in
vital organs [56]. Recently, gene expression studies in bovine
mammary tissues showed a differential abundance of mRNA
transcripts of NPC1 throughout the pregnancy-lactation cycle.
Interestingly, NPC1 mRNA levels were significantly reduced
during the dry period, but were subsequently increased after
parturition [57]. These findings suggest an involvement of
NPC1 in cholesterol trafficking to adapt to the requirements
for milk secretion. Data derived from MEC are lacking, but it
has been reported that plasma membrane cholesterol in other
polarized cells is higher in the apical than basolateral mem-
brane [6]. The trafficking of cholesterol synthesized in the ER
involve non-vesicular and vesicular transport processes [58,
59] that ultimately cargo cholesterol to the plasma membrane
for its release into milk. The oxysterol-binding protein
(OSBP) and OSBP-related proteins (ORP) are likely to be
predominant pathways for cholesterol transfer into and out of
the ER in MEC [59–61]. Type 2 ORP over-expression in
HeLa cells showed enhanced transfer of cholesterol from the
ER to the plasma membrane similarly as in CHO (Chinese-
hamster ovary) cells constitutively expressing ORP [62]. The
vesicle-mediated secretory pathway through the trans-Golgi
network (not illustrated in Fig. 1) is a likely route for choles-
terol trafficking from the ER towards other cellular compart-
ments including the apical plasma membrane. Interestingly,
the treatment of polarized hepatocytes with brefeldin A, an
inhibitor of transport from the ER to the Golgi network, did
not significantly delay the transfer of newly synthesized cho-
lesterol from the ER to the plasma membrane [63, 64]. It has
been also reported that in polarized cells cholesterol content
increases from low levels in the ER to intermediate levels in
the trans-Golgi network, and is highest in the plasma mem-
brane [59].
Mechanisms of Cholesterol Efflux at the Apical Plasma
Membrane
Mammary Cell Specific Secretion Mode
As illustrated in Fig. 1, cholesterol transport into milk involves
a specific secretion mode inherent to MEC, which implies a
continuous energy-independent transport of cholesterol
contained in milk lipid droplets [65–68]. Milk lipids are
secreted by alveolar MEC as emulsified globules surrounded
by a protein-rich polar lipid coat called the milk lipid droplet
membrane. The milk lipid droplets are synthesized in the ER
and migrate towards the apical membrane as they develop and
mature (Fig. 1) [65, 69]. At the apical plasma membrane
domain, lipid droplets are progressively enveloped by the
apical plasma membrane and pinched off into the alveolar
lumen. A detailed overview on lipid transport mechanisms in
the mammary gland and their importance for milk secretion is
also given in the article of McManaman in the present issue.
The plasma membrane derivative covering the lipid droplet
contains cholesterol and other phospholipid components. It
has been demonstrated that approx. 80 % of the total milk
cholesterol is found within the membrane surrounding the
milk lipid droplet [69, 70]. Similarly, the major fraction of
phospholipids (approx. 60 % of total milk phospholipids) is
also derived from the membrane of the milk lipid droplet. The
remaining part of both milk cholesterol and phospholipids are
J Mammary Gland Biol Neoplasia (2014) 19:43–58 47
found in skim milk [69, 70]. Whether the distribution of
cholesterol in different milk fractions is suggestive of
the secretory routes has not been specifically addressed
yet.
Active Cholesterol Transport
It is well established that in mammalian cells cholesterol is
transported by an energy-consuming mechanism that involves
the interaction of specific ABC transporters with their partners
such as a lipid-poor apolipoprotein (apo) A-1 which act as
cholesterol acceptors. ABC transporters are one of the largest
families of integral plasma membrane proteins involved in the
transport of various substrates including cholesterol and phos-
pholipids across cellular membranes. Seven subfamilies of
ABC transporters named from A to G have been identified
and characterized so far. They consist of intracellular nucleo-
tide binding domains and trans-membrane domains composed
of 6–11 membrane-spanning α-helices. ABC transporters are
categorized into full transporters when they contain two nu-
cleotide binding domains and two trans-membrane domains
(e.g. ABCA1), or half transporters with one nucleotide bind-
ing domain and one trans-membrane domain each (e.g.
ABCG1). The functional activity of ABC transporters re-
quires the hydrolysis of ATP bound to the intracellular nucle-
otide binding domains. It is established that ABC transporters
of the subfamily A differ from other ABC transporters by the
presence of two large extracellular domains which exhibit
conformational changes required for cholesterol transport fol-
lowing hydrolysis of ATP [71].
The ABC transporter-mediated cholesterol transport pro-
cess is important in maintaining cellular cholesterol homeo-
stasis as its dysfunction has been associated with the occur-
rence of various hereditary diseases such as Tangier disease or
familial HDL deficiency (mutations in ABCA1, [19, 72]),
pulmonary surfactant deficiency in newborns (ABCA3,
[73]), or Stargardt disease 1 (ABCA4) (for review see [74]).
ABCA7, another member of the A subfamily, is a full trans-
porter with highest homology to ABCA1 that has been iden-
tified at the plasma membrane [75], and in vitro studies
revealed that ABCA7 promotes the efflux of cellular phos-
pholipids onto lipoproteins [76]. Consistently, ABCA7 null-
mice show reduced HDL levels and alterations in adipose
mass [77, 78].
A prerequisite for an involvement of ABC proteins in
transcellular cholesterol transport in the mammary gland is
their plasma membrane localization in mammary tissue. In-
terestingly, studies by Reinhardt and Lippolis [79] and Mani
et al. [67] identified the presence of ABC transporter proteins
on the plasma membrane covering the milk fat globule pre-
pared from human and cow milk, supporting their potential
role in cholesterol transfer into milk. In this context, ABC
transporters belonging to the subfamilies A and G seem to
represent the most interesting candidates as their implication
in cholesterol transport in other polarized cell types had been
repeatedly shown [80, 81].
Besides ABC transporters, a wide variety of proteins such
as butyrophilin, xanthine oxidase, or adipophilin are found in
the membrane enveloping the lipid droplets. In a recent study,
the proteomic characterization of human milk fat globule
(MFG) membrane has identified the presence of more than
190 proteins which are important for diverse cellular functions
such as cellular growth, immune function, or cell signaling
[82, 83]. Comparative analysis showed that the protein ex-
pression in MFG membrane prepared from mature milk is
associated with the progression of lactation [83]. For instance,
it has been shown that butyrophilin, xanthine oxidase and
adipophilin which form a complex implicated in lipid droplet
formation and secretion [84–86] were individually up-
regulated in the membrane of MFG prepared from mature
milk as compared to colostrum [83]. In contrast, the expres-
sion of the cholesterol acceptor apoA-I was down-regulated
[3]. ABCA1 and AGCG1 protein have been identified in the
MFG membrane isolated from mature milk, strongly suggest-
ing the presence of these transporters at the apical membrane
[67]. However, it is currently unclear as to whether those
energy-consuming transporters are operational in the MFG
since they would require cellular ATP.
Expression and Localization of ABCA Transporters
Studies investigating the expression of ABCA transporters in
the mammary gland are scarce. Comparing the abundance of
ABCA1 among human tissues, it was shown that ABCA1
mRNA transcripts were higher in placenta, liver, lung, adrenal
glands and foetal tissues than in mammary gland [87]. A
similar pattern has also been reported by other investiga-
tors who indicated a low expression level of ABCA1
mRNA in bovine mammary tissues as compared to lung
or liver [88]. Mani et al. [4] compared the expression of
ABCA1 and ABCA7 among three mammalian species.
The mRNA expression of ABCA1 was significantly
higher in non-lactating than in lactating murine mammary
tissues. However, ABCA7 mRNA abundance was similar
between these two functional states of the mammary
gland. In bovine, however, the mRNA expression of
ABCA1 and ABCA7 was significantly greater in non-
lactating than in lactating mammary tissues. In this con-
text it should be noted that depending on the develop-
mental and functional stages, the mammary gland con-
tains variable amounts of adipocytes [89], which are
known to express also cholesterol transporters [90]. In
general, these findings suggest a variable importance of
the transporters in cholesterol transport during non-
lactating and lactating states of the mammary gland [4,
57, 67]. An inverse association between the mRNA levels
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of NPC1 and ABCA1 during the pregnancy-lactation cy-
cle was observed. In fact, an increase of ABCA1 during
the non-lactating phase was paralleled by a marked de-
crease of the mRNA level of NPC1 [57].
As summarized in Table 3 and Fig. 2, immunohistochem-
ical studies have identified the cellular and sub-cellular local-
izations of ABCA transporters in mammary tissues and cells.
The comparison of ABCA1 localization among mouse, hu-
man and bovine mammary gland tissues obtained at different
physiological states revealed that this protein was localized at
both basal and apical sides of secretory mammary cells [4].
ABCA1 and ABCA7 proteins were stained in the alveolar and
ductal epithelium in lactating human mammary tissues (with
higher intensity for ABCA1 than ABCA7). In non-lactating
mammary tissue ABCA1 and ABCA7 were also detected in
endothelial cells and adipocytes (Table 3 and [4]). The pres-
ence of ABCA1 in murine and bovine mammary tissues
supports the assumption that the transporter plays a role in
lipid storage and possibly in their transfer across the mammary
epithelium. As indicated in Table 3, ABCA1 and ABCA7
positive staining was completely absent in MEC of non-
lactating murine mammary tissue while ABCA1-positive
mammary adipocytes were detected [4]. In lactating murine
tissues ABCA1 and ABCA7 positive cells were mainly de-
tected in the glandular epithelium with diffuse cytoplasmic
distribution. In addition, positive staining for ABCA1 and
ABCA7 was localized in mammary adipocytes of lactating
murine mammary tissues. To date studies analyzing the ex-
pression of these cholesterol transporters in pure MEC instead
of whole mammary tissue which consists of various different
cell types are still missing.
Studies comparing healthy and diseased human breast tis-
sues showed a strong expression of ABCA1 and ABCA3 in
normal mammary gland epithelium. Moreover, intracellular
localization of ABCA1 has been identified in human breast
cancer tissues [91]. With respect to the subcellular distribution
ABCA1 has been detected mainly on the plasma membrane
and some intracellular compartments like the Golgi network
and recycling endosomes [92].
Expression and Localization of ABCG Transporters
Among transporters of this sub-family ABCG1 shows
structural and expressional similarities with ABCA1. It
is established that ABCG1 mediates the cellular choles-
terol efflux to HDL but not to lipid-poor apoA-I. As
shown in Table 3 and Fig. 3, the mRNA transcripts
encoding ABCG1 and corresponding protein were iden-
tified in mouse MEC and mammary adipocytes [4]. The
expression level of ABCG1 in mammary adipocytes was
persistant throughout lactation and pregnancy whereas it
was absent in MEC of human and murine non-lactating
mammary tissues [4], suggesting a potential role of
ABCG1 in regulating cholesterol storage in mammary
tissues. In contrast to the expression pattern in mouse
mammary gland tissues, ABCG1 was localized in the
mammary epithelium of both non-lactating and lactating
bovine mammary tissues [4]. Generally, the expression
pattern in the mammary gland may support a potential
role of ABCG1 in lipid transport. This is in line with
studies in other cell types suggesting that ABCG1 plays
a role in cholesterol movements and trafficking to the
plasma membrane [93, 94].
The mRNA transcripts encoding ABCG5 and ABCG8
were identified with relatively low abundance in bovine mam-
mary gland tissues in few previous studies [88, 95], suggest-
ing that these obligate heterodimers might play a minor role in
cholesterol transport in this tissue. However, the protein ex-
pression and functional activity of ABCG5 and ABCG8 in
mammary tissue has not been elucidated so far. These two
transporters were found to be important in the transport of
dietary cholesterol and other sterols in the liver and intestine
[96–98]. Mutations in either ABCG5 or ABCG8 cause
sitosterolemia, a rare autosomal recessive disorder character-
ized by accumulation of both plant-derived sterols and animal-
derived sterols (cholesterol) in plasma and tissues, leading to
the development of xanthomas [99].
Table 3 Species-based protein localization of candidate ABC trans-
porters in various mammary cell types
Species/Protein Non-lactating1 Non-lactating2 Lactation
Cell type MEC AD MEC AD MEC AD
Homo sapiens
ABCA1 ++ +/− ++ + +++ +
ABCG1 − + − + + +
ABCA7 + − ++ −/+ ++ −/+
Non-lactating Early lactation Mid-lactation
MEC AD MEC AD MEC AD
Mus musculus
ABCA1 − +++ ++ +++ ++ +++
ABCG1 − − + ++ ++ +/−
ABCA7 − − ++ +++ + +
Non-lactating Early lactation Mid-lactation
MEC SC MEC SC MEC SC
Bos taurus
ABCA1 +++ + +++ − +++ +
ABCG1 + − ++ − ++ −
Estimated expression grade for different mammary cell types is indicated
as ‘−’, absent; ‘−/+’, weak staining intensity; and ‘+’ to ‘+++’, low- to
high-staining intensity. Non-lactating (1) = ante-menopausal; Non-lactat-
ing (2) = post-menopausal. This table has been adapted from [4] and is
published with permission from the American Physiological Society
MEC alveolar mammary epithelial cells, AD mammary adipocytes, SC
stromal cells
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Diffusion of Cholesterol
Milk contains diverse soluble proteins such as albumins which
bind cholesterol and therefore could potentially act as accep-
tors during the transfer across the apical membrane. Accord-
ingly, it was observed that primary bovine MEC preloaded
with 3H-cholesterol were able to efflux greater amounts of
cholesterol when the culture medium was supplemented with
bovine serum albumin, supporting a possible carrier-mediated
diffusion process for cholesterol. Thereby cholesterol efflux in
the presence of bovine serum albumin was not inhibited by
micromolar concentrations of probucol, an inhibitor of
ABCA1 (unpublished data). On the other hand, when primary
bovine MEC were preloaded with 3H-cholesterol retrograde
diffusion of the isotope into the mediumwas observed even in
the absence of cholesterol acceptor [44], suggesting passive
diffusion of cholesterol across the plasma membrane. In this
context, some studies have reported that cholesterol can pass
through the plasma membrane by passive diffusion through
the aqueous phase of the surroundings [100, 101]. Thus, as
depicted in Fig. 1, diffusion of cholesterol likely represents an
additional transfer mechanism of cholesterol into milk.
Recent Advances in Investigating Cholesterol Binding
and Transport in the Mammary Gland
In general, the methods to study cholesterol transport and
distribution in biological membranes are based on the
measurement of radioactively labeled cholesterol (e.g. with
3H, 14C, etc.) or fluorescent cholesterol [54]. With respect to
the use of fluorescent cholesterol derivatives, it was initially
suspected that the fluorophore might change the properties of
cholesterol and therefore impairs its transport and distribution
among cellular membranes [102]. However, relatively recent
studies comparing the transport of 3H cholesterol and BODIPY-
cholesterol in J774 cells demonstrated that BODIPY-
cholesterol provides an efficient measurement of cholesterol
efflux compared with 3H-cholesterol [103] suggesting that this
fluorescent compound is also suitable for cholesterol studies in
MEC. The transport and distribution of de novo synthesized
cholesterol in the plasma membrane can be estimated by load-
ing cells with radioactively labeled acetate and then measuring
the resulting amount of radioactive cholesterol in the plasma
membrane. Cholesterol transport and distribution can be esti-
mated by using the fluorescent detergent filipin which binds
specifically to unesterified cholesterol [104]. In a study using
bovine mammary tissues and isolated milk fat globules, filipin
has already been efficiently used to stain the milk fat globule
membrane enveloping the core containing triglycerides [67].
Other methods can be used to quantify total cholesterol in cells
and tissues. They include the measurement of cellular choles-
terol by gas chromatography—mass spectrometry [105] or by
colorimetric enzymatic assays [44]. The three-dimensional cul-
ture systemwhereMEC grow on coated surface and formmilk-
secreting clusters (i.e. mammospheres) may also represent an
interesting experimental system to study cholesterol transport.
This model has been already applied to mouse primary
Fig. 2 Immunohistological localization of the cholesterol transporter
ABCA1 in non-lactating and lactating mammary tissues of different
species. Mammary gland sections of human, murine and bovine origin
were stained with a specific antibody against ABCA1. For details on the
methodology see [4]. In human breast samples NL1 and NL2 indicate the
non-lactating antemenopausal and postmenopausal state, respectively; L
lactating. Murine and bovine samples: NL non-lactating, EL early lacta-
tion (mouse: 1–6 days after parturition; cow: day 14 of lactation), ML
mid-lactation mouse: 9–12 days after parturition; cow: day 88 of lacta-
tion), A adipocyte. Black arrows indicate mammary epithelial cells.
Magnification: × 40. Data are adapted from [4] with permission from
the American Physiological Society
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mammary cells [106] to investigate 45Ca transport in
MEC and could presumably be adapted for cholesterol
transport studies.
A scintillation proximity assay has been developed to study
endosomal trafficking of radiolabeled cholesterol in living
non-polarized cells [107]. This methodological approach
could be also used to study the involved transport in mamma-
ry cells because intracellular cholesterol transport pathways
are similar between polarized and unpolarized cells. The dif-
ficulty regarding the quantitative measurement of cholesterol
in specific cellular compartments is based on the fact that, as
described above, cholesterol can diffuse from the plasma
membrane, undergoes intracellular trafficking, and can be
stored in esterified or unesterified pools which are distributed
in different intracellular compartments.
In a recent study [44], the kinetics of cholesterol uptake and
processing by MEC as well as the binding determinants of the
components of the HDL cholesterol transport system (choles-
terol and apoA-I) have been determined in plasma membrane
microsomal preparations prepared from lactating and non-
lactating mammary gland tissues. It has been shown that
in vitro cholesterol transport into and out of the cells has been
characterized by an inversion point, which has an impact on
the levels of cholesterol transported, compartmentalized, and
released from the cells. By considering additionally the bind-
ing properties of the constituents of the HDL transport system,
a robust and comparably fast cell-based cholesterol efflux
assay was established and used to decipher the directionality
of cholesterol transport in MEC. In this context, it was shown
that, similarly to other cell types, cholesterol transport inMEC
involves a direct interaction of ABCA1 with apoA-I. The
binding of 125I-apoA-I to isolated plasma membrane vesicles
was of high affinity and could be competitively inhibited by
an ABCA1 inhibitor. At steady-state conditions the transport
of cholesterol appeared to be more pronounced at the
basolateral domain of the plasma membrane as compared to
the apical side [44].
Recently, Sorg and coworkers [108] have shown that pri-
mary MEC used for functional in vitro analyses can also be
successfully isolated from milk. The gene expression analysis
of traits (e.g. prolactin receptor) and functional investigations
(e.g. cholesterol efflux) performed with those cell preparations
indicated that MEC isolated from milk are comparable, and in
some aspects even advantageous to MEC prepared from
mammary tissue [108]. Hence, the isolation of MEC using
milk seemed to significantly lower the contamination with
other mammary cell types (e.g. fibroblasts).
Regulation of Cholesterol Transport and Synthesis
In mammary tissues, the homeostatic control of lipids includ-
ing cholesterol is exerted both through the regulation of the de
novo synthesis of lipids and via the control of uptake and
efflux [109–111]. The regulation of cholesterol uptake, intra-
cellular transport, and efflux in the mammary gland involves
the action of cellular enzymes and transcription factors. It has
been shown that mammary tissues express 3-hydroxy-3-meth-
ylglutaryl-CoA (HMG-CoA) reductase, which is a rate-
limiting enzyme in the de novo synthesis of cholesterol from
acetate via the mevalonate pathway. Various studies reported
the expression of HMG-CoA reductase in mammary tissues
and its regulatory mechanisms [112–114]. Hormones promot-
ing intracellular increase of cAMP stimulate the activity of
HMG-CoA reductase and the uptake of LDL-cholesterol.
With the increase of intracellular cholesterol, the expression
of the LDL receptor and the activity of both HMG-CoA
reductase and LAL are suppressed, whereas ACAT is induced.
These changes are accompanied by decreasing cholesterol
uptake, synthesis and de-esterification.
When intracellular cholesterol concentrations are low, the
situation is reversed. Sterol response element binding proteins
(SREBPs) 1 and 2 are important regulators of lipid synthesis.
They bind the sterol responsive element located in the pro-
moter region of the response genes [115]. SREBP-1c activates
genes involved in triglyceride synthesis when cholesterol
levels are high, whereas SREBP2 promotes, among other
pathways, the expression of cholesterol synthetic genes when
cellular cholesterol levels are low. Expression studies using
bovine mammary tissues revealed that mRNA transcripts
encoding SREBP1 and SREBP2 were markedly suppressed
at the end of the previous lactation, and were strongly en-
hanced after parturition and throughout lactation indicating
the critical importance of SREBPs in maintaining a balanced
lipid content in the milk [57].
An increase of intracellular cholesterol levels is accompa-
nied by an enhanced synthesis of oxysterols, which are
oxydized derivatives of cholesterol playing important
functions in lipid metabolism [116, 117]. They act as
agonists for the liver X receptors (LXRs), cytosol-located
transcription factors, which exist as α and β isoforms
[118]. It is considered that LXRα acts as a regulator of
milk fat synthesis as its expression level was increased
during the transition from pregnancy to lactation [57].
Furthermore, stimulation of bovine MEC with a synthetic
agonist of LXRα (TO901317) led to an increase of de novo
fatty acid synthesis [119]. Besides, it has been shown that
LXRα regulates the transcription and expression of cho-
lesterol transporters such as ABCA1 [120]. Recent find-
ings demonstrated that stimulation of primary bovine MEC
with TO901317 increased both the mRNA abundance of
ABCA1 and the cellular efflux of 3H-cholesterol (authors’
unpublished observation).
Other regulatory genes influencing cholesterol transport in
the mammary gland include the nuclear receptor peroxisome
proliferator-activated receptors (PPARs), which act as
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nutritional sensors regulating a variety of homeostatic func-
tions including metabolism, inflammation and development
[115]. These nuclear receptors exist as isoforms α, γ and β/δ
which are expressed in a variety of tissues and cells including
the mammary gland and mammary cell line MAC-T [114].
The contribution of PPARs in regulating milk lipid synthesis
across species has been discussed, and it is assumed that
PPARγ plays a role in controlling the milk lipids in ruminants,
but probably not in certain other species such as mouse [121,
122]. Regarding the effect on cholesterol synthesis, PPARα
was shown to up-regulate the de novo synthesis by altering the
activity of HMG-CoA reductase [123].
PPARα is a main metabolic regulator for catabolism
whereas PPARγ regulates anabolism or storage [115]. PPAR
agonists can activate PPARα which in turn activates the
transcription of retinoid X receptor and LXR genes in macro-
phages, leading to enhanced transcription of ABCA1 and
ABCG1 [124]. A role of PPARγ in the regulation of choles-
terol transport in mammary tissues has been suggested by
studies revealing a differential expression pattern of this gene
during the pregnancy-lactation cycle [57].
In addition to the abovementioned regulatory factors, the
expression and activity of lipid transporters and their modu-
lators are tightly regulated by hormones, which are typically
altered during the pregnancy-lactation cycle. It is well accept-
ed that prolactin is a regulator of the synthesis of milk com-
ponents. In rats a marked reduction of mammary LPL activity,
an enzyme implicated in cholesterol uptake (Fig. 1), was
observed after hypophysectomy which was abolished after
prolactin injection [125], supporting a potential involvement
of prolactin in cholesterol uptake. However, a more complex
hormonal regulation of mammary LPL activity was also pos-
tulated involving additional hormones such as growth hor-
mone and its related growth factors [126, 127]. Interestingly,
the transcription factor prolactin regulatory element binding
(PREB) is present in the promoter region of ABCA1 [128],
and transcripts of PREB were found in human and bovine
MEC (unpublished data).
Recent in vitro studies in our laboratories also revealed that
primary bovine MEC show increased ABCA1-mediated cho-
lesterol efflux after stimulation with hydrocortisone, insulin,
estradiol and progesterone (unpublished data). In addition,
treatment with the synthetic agonist of cyclic AMP
(forskolin) enhanced ABCA1-mediated cholesterol efflux
(unpublished data). Furthermore, it has been observed that
ABCA1-mediated cholesterol efflux in primary bovine MEC
is suppressed by treatment with inhibitors of JAK-2 and
MAPK, two effector proteins amongst others, which are
downstream targeted by activation of the prolactin receptor,
suggesting a potentially regulatory effect of prolactin on the
transporter. As depicted in Fig. 4, future investigations should
be addressed to decipher the potential crosstalk between
ABCA1 and hormones such as prolactin and to clarify
potential interplays between transporters, hormones and sig-
naling pathways in the mammary gland. This is of particular
interest as signaling pathways and downstream targets for
insulin, glucocorticoids and progesterone are not well under-
stood [129].
Mammary Gland Function and Reverse Cholesterol
Transport
Cellular cholesterol efflux, its loading onto lipid-poor apoA-I
or other cholesterol acceptors, and the subsequent transport
via HDL particles to the liver is an important physiological
mechanism termed reverse cholesterol transport. It allows the
retrograde transport of cholesterol from peripheral cells such
as macrophages to the liver for excretion, and involves the
contribution of cholesterol transporters such as ABCA1 [19].
Severe disturbances of this transport mechanism lead to an
intracellular accumulation of cholesterol in form of cholesteryl
esters and to the formation of foam cells, thereby accelerating
the development of atherosclerosis [130, 131]. The initial
process of foam cell formation is characterized by a migration
of blood monocytes into the vascular wall followed by their
differentiation into macrophages [132]. Cellular cholesterol
homeostasis depends on the equilibrium between diverse im-
portant cellular processes. These include i) the uptake of
cholesterol by receptor-mediated pathways, ii) de novo syn-
thesis via the HMG-CoA reductase pathway, iii) the controlled
esterification of free cholesterol mediated by ACAT, and its
hydrolysis by CEH, and iv) the cellular efflux of free choles-
terol by cholesterol transporters such as ABCA1. Despite the
obvious histological and functional differences between MEC
and macrophages, it should be considered, however, that the
entire machinery of receptors, enzymes and transporters im-
plicated in reverse cholesterol transport is also expressed in
MEC. Gene expression measurements of ABCA1 at different
stages of the pregnancy-lactation cycle showed that ABCA1
mRNA levels were significantly higher in non-lactating as
compared to lactating mammary tissues [57]. However, the
reversible adipocyte-to-epithelium and epithelium-to-
adipocyte trans-differentiation occurring in mammary tissues
during lactation and non-lactation, respectively, variably in-
fluence the adipocyte content of the tissue [89]. Data reported
by Mani and colleagues have not been normalized for this
aspect, thus the presence of substantial amounts of adipocytes
in the non-lactating mammary tissue is likely to contribute to
the increased ABCA1 mRNA abundance found in non-
lactating total mammary tissue. Nonetheless, localization
studies and functional investigations in bovine mammary
tissues and cells showed that ABCA1 protein is present on
the plasma membrane of mammary secretory cells, and that
ABCA1-mediated cholesterol efflux occurs both at the apical
membrane facing the alveolar milk and at the basolateral
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membrane oriented towards the bloodstream. Indeed, in
steady-state culture conditions cholesterol efflux was more
pronounced at the basolateral side than at the apical membrane
[44]. Therefore, it appears likely that MEC release cholesterol
back into the blood circulation when milk synthetic activity is
markedly reduced (or suppressed) to avoid intracellular cho-
lesterol accumulation (e.g. during non-lactating periods). In
conclusion, the functional stage of the mammary gland and
the herewith associated differential activity of cholesterol
transporters may have a yet underestimated impact on blood
cholesterol levels, HDL formation and reverse cholesterol
transport.
Summary, Conclusions, and Research Perspectives
The present review has summarized the state-of-art knowl-
edge on cholesterol transport mechanisms and regulation in
the mammary gland, and has briefly discussed the multiface-
ted role of cholesterol with respect to health and disease. So
far, data on cholesterol transport in the mammary gland are
essentially derived from expressional studies suggesting the
importance of enzymes, receptors, and transporters in the
regulation of cholesterol homeostasis in mammary tissues.
Based on these findings, the implication of ABC and NPC
transporters, lipases, ACAT, and lipoprotein receptors such as
LDL or SR-B1 in cholesterol uptake, trafficking, storage, and
release into milk has been highlighted. Regarding ABC
transporters, the role of ABCA1 and its interacting partner
apoA-I in cholesterol transport in the mammary gland has
been the most studied so far, i.e. by using both tissue- and
cell-based approaches. Complementary investigations are
warranted to clarify the functional role of ABCG1,
ABCG5/ABCG8 as well as ABCA7, whose mRNA and/
or protein expression in the mammary tissues have also
been reported.
Recent cell-based work on directional aspects suggests
that cholesterol transport in MEC is more pronounced at
the basolateral side implying that cholesterol transfer in
the mammary gland is not a unidirectional process. Ac-
cordingly, elucidation of whether the possible reverse cho-
lesterol transport by MEC is a continuous or a stage-
specific process is of major importance. Further investiga-
tions should take advantage of the already established
Transwell® system and test MEC cultured in conditions
mimicking in vivo physiological stages to determine 1) if
cholesterol is predominantly transported either via energy-
dependent or energy-independent mechanisms, 2) whether
these processes, including the transport orientation, are
dependent of the physiological and functional stage of
the mammary gland, 3) how key hormones specific for
the pregnancy-lactation cycle affect these processes. Three-
dimensional cell culture systems and the use of labeled
(including fluorescent) cholesterol derivatives to investigate
cholesterol transport in MEC could majorly improve our
understanding of mechanisms determining the milk com-
position. In this context one of the crucial issues faced by
the researchers is associated with the heterogeneity of cell
types present in primary cell preparations, and the diffi-
culty of maintaining highly pure primary MEC cultures
Fig. 3 Immunohistochemical localization of ABCG1 in non-lactating
and lactating mammary tissues of different species. Mammary gland
sections of human, murine and bovine origin were stained with a specific
antibody against ABCG1. For details on the methodology see [4]. In
human breast samples NL1 and NL2 indicate the non-lactating
antemenopausal and postmenopausal state, respectively; L lactating.
Murine and bovine samples:NL non-lactating, EL early lactation (mouse:
1–6 days after parturition; cow: day 14 of lactation), ML mid-lactation
mouse: 9–12 days after parturition; cow: day 88 of lactation), A adipo-
cyte. Black arrows indicate mammary epithelial cells. Magnification: ×
40. Data are adapted from [4] with permission from the American
Physiological Society
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over several passages. In this regard, the use of MEC
extracted from milk might be an efficient alternative to
MEC isolated from mammary gland tissue.
Among other cell biological aspects, the clarification of
intracellular signaling pathways (Fig. 4) associated with the
function of ABC transporters in the mammary gland is of
major importance. Such investigations will not only contribute
to unravel the molecular mechanisms of cholesterol transport,
but also to potentially identify additional biological functions
of ABC proteins beside lipid transfer into milk. Moreover,
additional in vivo studies are required to identify to which
extent ABC transporters are crucial to determine the milk
cholesterol content. Strategies applicable in this context may
derive from genetic models summarized elsewhere [133],
which have been previously used in the context of in vivo
reverse cholesterol transport studies. For instance, the knock-
out mouse models of ABCA1 [134], ABCG5/ABCG8 [135],
SR-B1 [136], or apoA-I [137] could be used to determine how
these proteins affect milk cholesterol content. In addition, our
understanding of cholesterol metabolism in the mammary
gland could be enhanced by using SCAP null mice [138,
139] to investigate the importance of SREBP2 in cholesterol
biosynthesis and transport as well as its hormonal regulation,
or by investigating LXRα knockout mice [140] to test the role
of LXRα in mammary gland cholesterol homeostasis and
milk composition.
Ultimately the acquired in vitro and in vivo knowl-
edge may also lead to a better understanding of the
patho-physiological and nutritional aspects of cholesterol.
This could contribute to design strategies for the optimi-
zation of milk cholesterol content, which should match
both elevated requirements of infants during the early
postnatal life and the necessity to prevent cardiovascular
diseases due to high dietary cholesterol intake in milk
consumers of older age.
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Fig. 4 Potential ABCA1 signaling and crosstalk in mammary epithelial
cells (MEC). The main signaling mechanism (A) associated with choles-
terol efflux from MEC involves the cell surface interaction of apoA-I with
ABCA1 (step 1) that induces autophosphorylation of the ABCA1-associ-
ated janus-kinase (Jak)-2 [142] (step 2). The latter activates downstream
cytosolic effector proteins such as signal transducer and activator of tran-
scription (STAT) (step 3) which, after dimerization, is translocated into the
nucleus to regulate the gene transcription (step 4) followed by the cell
biological responses (step 5). Mechanism (B) shows the signaling pathway
initiated by prolactin/prolactin receptor (PLR) interaction at the cell surface
which involves similar steps as indicated for the apoA-I/ABCA1 signaling
pathway. However, it has not been investigated so far whether signaling
initiated by prolactin has regulatory effects on cholesterol efflux. Additional
effects on cholesterol efflux could be initiated through mechanism (C)
which involves the interaction of glucocorticoids with its receptor (GR)
by non-genomic and (or) genomic pathways. In both cases the complex
might directly target downstream effector proteins such as STAT, but,
similar to pathway B, the importance of this mechanism for cholesterol
efflux in the mammary gland has not been studied yet. Finally, other factors
might also be involved in the stimulation of STAT (mechanism D). Wheth-
er crosstalk exists between prolactin and ABCA1 signaling requires addi-
tional investigations
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